DE69913351D1 - Metallkomplexe von chlorinderivaten zum abschirmen von röntgenstrahlen - Google Patents

Metallkomplexe von chlorinderivaten zum abschirmen von röntgenstrahlen

Info

Publication number
DE69913351D1
DE69913351D1 DE69913351T DE69913351T DE69913351D1 DE 69913351 D1 DE69913351 D1 DE 69913351D1 DE 69913351 T DE69913351 T DE 69913351T DE 69913351 T DE69913351 T DE 69913351T DE 69913351 D1 DE69913351 D1 DE 69913351D1
Authority
DE
Germany
Prior art keywords
shielding
metal complexes
chlorine derivatives
ray rays
ray
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69913351T
Other languages
English (en)
Other versions
DE69913351T2 (de
Inventor
Katsuo Aizawa
Shinjiro Sumi
Hirotada Takahashi
Noriaki Aman
Yoshihiko Terayama
Shuichi Gomi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Publication of DE69913351D1 publication Critical patent/DE69913351D1/de
Application granted granted Critical
Publication of DE69913351T2 publication Critical patent/DE69913351T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0085—Mossbauer effect therapy based on mossbauer effect of a material, i.e. re-emission of gamma rays after absorption of gamma rays by the material; selective radiation therapy, i.e. involving re-emission of ionizing radiation upon exposure to a first ionizing radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/545—Heterocyclic compounds
    • A61K47/546—Porphyrines; Porphyrine with an expanded ring system, e.g. texaphyrine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69913351T 1998-07-10 1999-07-12 Metallkomplexe von Chlorinderivaten zum Abschirmen von Röntgenstrahlen Expired - Lifetime DE69913351T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP19571798 1998-07-10
JP19571798 1998-07-10
PCT/JP1999/003752 WO2000002882A1 (fr) 1998-07-10 1999-07-12 Nouveaux complexes metalliques intercepteurs de rayons x a base de derives de chlore

Publications (2)

Publication Number Publication Date
DE69913351D1 true DE69913351D1 (de) 2004-01-15
DE69913351T2 DE69913351T2 (de) 2004-09-16

Family

ID=16345803

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69913351T Expired - Lifetime DE69913351T2 (de) 1998-07-10 1999-07-12 Metallkomplexe von Chlorinderivaten zum Abschirmen von Röntgenstrahlen

Country Status (9)

Country Link
US (1) US6413495B1 (de)
EP (1) EP1097935B1 (de)
JP (1) JP3692298B2 (de)
AT (1) ATE255583T1 (de)
AU (1) AU748625B2 (de)
CA (1) CA2336582C (de)
DE (1) DE69913351T2 (de)
ES (1) ES2212577T3 (de)
WO (1) WO2000002882A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2301480T3 (es) * 1999-04-02 2008-07-01 Meiji Seika Kaisha, Ltd. Inhibicion de la reestenosis vascular despues de angioplastia.
WO2002041782A2 (en) 2000-11-24 2002-05-30 Koninklijke Philips Electronics N.V. Diagnostic imaging interventional apparatus
EP1351619A4 (de) 2001-01-16 2011-01-05 Microdexterity Systems Inc Chirurgischer manipulator
IL147898A (en) * 2002-01-30 2007-05-15 Yuval Golan A method of treating cancer based on the Ugar effect
CN2885311Y (zh) 2006-01-18 2007-04-04 郑成福 经尿道光动力疗法前列腺治疗仪
US10376711B2 (en) * 2003-03-14 2019-08-13 Light Sciences Oncology Inc. Light generating guide wire for intravascular use
JP4960602B2 (ja) * 2005-04-15 2012-06-27 三鷹光器株式会社 蛍光観察時の明視野光源及びそれを搭載した手術顕微鏡
ES2627420T3 (es) * 2009-06-12 2017-07-28 Erasmus University Medical Center Rotterdam Nanofotomedicamentos destinados al tratamiento fotodinámico del cáncer
RU2455039C1 (ru) * 2011-03-14 2012-07-10 Виктор Александрович Борисов Способ фотодинамической терапии злокачественных новообразований
US10766915B2 (en) 2013-03-15 2020-09-08 Sherri Ann McFARLAND Metal-based coordination complexes as photodynamic compounds and their use
US10149493B2 (en) 2015-04-29 2018-12-11 Corn Products Development, Inc. Flours that improve the crispness of battered potatoes
CA2999888C (en) 2015-09-24 2024-04-09 Abvitro Llc Affinity-oligonucleotide conjugates and uses thereof
PL236093B1 (pl) 2017-07-04 2020-11-30 Dominika Szczepaniak Rozpuszczalne w wodzie kompleksy złota (III), sposób wytwarzania rozpuszczalnych w wodzie kompleksów złota (III) i ich zastosowanie
PL244960B1 (pl) 2021-02-15 2024-04-08 Dominika Szczepaniak Zastosowanie rozpuszczalnych w wodzie kompleksów złota (III)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4693885A (en) * 1984-07-18 1987-09-15 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
GB8426102D0 (en) * 1984-10-16 1984-11-21 Ici Plc Thermal transfer printing
US4921973A (en) * 1984-12-10 1990-05-01 Johnson Matthey Inc. Platinum complexes and the like
US4815447A (en) * 1985-03-19 1989-03-28 Mills Randell L Mossbauer cancer therapy
US4656186A (en) * 1985-04-30 1987-04-07 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
DE3827940A1 (de) * 1988-08-13 1990-03-01 Schering Ag 13,17-propionsaeure- und propionsaeurederivat- substituierte porphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
JP3253663B2 (ja) * 1992-01-20 2002-02-04 タマ生化学株式会社 放射線増感剤

Also Published As

Publication number Publication date
EP1097935A4 (de) 2002-01-30
EP1097935B1 (de) 2003-12-03
ES2212577T3 (es) 2004-07-16
WO2000002882A1 (fr) 2000-01-20
CA2336582C (en) 2006-06-06
US6413495B1 (en) 2002-07-02
EP1097935A1 (de) 2001-05-09
AU748625B2 (en) 2002-06-06
ATE255583T1 (de) 2003-12-15
CA2336582A1 (en) 2000-01-20
JP3692298B2 (ja) 2005-09-07
AU4651099A (en) 2000-02-01
DE69913351T2 (de) 2004-09-16

Similar Documents

Publication Publication Date Title
DE69913351D1 (de) Metallkomplexe von chlorinderivaten zum abschirmen von röntgenstrahlen
NO20006155D0 (no) Texaphyrinkonjugater og anvendelse derav
RU92016479A (ru) Применение 5,10,15,20-тетракис (4-карбоксифенил) порфина для обнаружения и лечения рака легких
NO20040239L (no) Konjugater av makrosykliske metallkomplekser med biomolekyler og anvendelse derav til fremstilling av midler for anvendelse i NMR- og røntgendiagnose, samt ved strålebehandling
DE3751809D1 (de) Intraoperative erstellung des befundes und tumor-therapie mittels endoskop
TR200003879T2 (tr) İn vivo ışın tedavisine duyarlılaştırıcı özelliklere sahip farnesil protein transferaz inhibitörleri@
AU6198086A (en) Agents for use in tumour diagnosis, imaging, localization or treatment
NO994932L (no) Blandinger og fremgangsmåter for behandling og diagnose av brystkreft
ATE262515T1 (de) Discodermolide verbindungen und deren pharmazeutische zusammensetzungen zur krebstherapie
ATE306281T1 (de) Antivirales mittel in kombination mit strahlentherapie zur verwendung in der behandlung von krebs
GB2393123A (en) Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy
IL97055A0 (en) Pharmaceutical compositions for sensitizing tumor cells comprising quinazolinedione derivatives
NO178571C (no) Analogifremgangsmåte for fremstilling av et bifunksjonelt chelateringsmiddel
MX9200413A (es) Composicion farmaceutica para el tratamiento y/o diagnostico de tumores de tejido blando.
DK0730871T3 (da) Radioaktivt kompleks og anvendelsen heraf til strålebehandling
ATE182077T1 (de) Benzazole derivate als therapeutische mittel
NO995109L (no) Formuleringer inneholdende 1,2,4-benzotriazinoksyder
SE8505315L (sv) Anordning for stralfeltsavskermning vid radioterapi
DK1154798T3 (da) Molekyler til behandling og diagnose af tumorer
Oren et al. Exposure to ultraviolet B radiation during phototherapy.
GR880100589A (en) Metalloporfyrines for the inversion of the toxic activity for the tumors treatment
Peterson Prevention of oral complications in cancer patients
DK6886A (da) Middel til at haeve ph-vaerdien af tandplak og fremgangsmaade til fremstilling af midlet
AU8436791A (en) Use of radioactive metal ion complexes with all-cis-1,3,5-triamino-2,4,6-cyclohexantriol and their derivates for x-ray diagnosis and in tumor therapy as well asfor producing x-ray diagnostic and tumor therapy agents
AU4209097A (en) Breast carcinoma-associated gene

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1097935

Country of ref document: EP

Representative=s name: VOSSIUS & PARTNER, 81675 MUENCHEN, DE